Chester County News and Community Website
Neuronetics, Inc. (NASDAQ: STIM), headquartered in Malvern, PA, is a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders.
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM), a medical technology firm, awarded Restricted Stock Units (RSUs) equivalent to 55,650 shares of common stock to thirteen newly hired non-executive employees on …
Neuronetics Awards Stock Options to New Employees as Inducement Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has announced that the U.S. Food and Drug Administration (FDA) has cleared NeuroStar TMS (transcranial magnetic stimulation) for use as a first-line add-on …
FDA Clears NeuroStar TMS Therapy for Adolescents with Depression, A First in the Field Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM), a leader in neurohealth technology, is set to unveil its financial and operational results for the first quarter of 2024 on Tuesday, May …
Neuronetics Announces Q1 2024 Earnings Release and Conference Call Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has announced the publication of a groundbreaking study in the prestigious journal Brain Stimulation. The research provides new insights into the effectiveness of …
New Study Offers Hope for Depression Patients Undergoing TMS Therapy Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM), a pioneer in neuroscience-based healthcare solutions, has taken a decisive step to attract and retain top-tier talent by granting inducement awards of Restricted …
Neuronetics Bolsters Talent Pool with Strategic Stock Incentives for New Hires Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced this week that the U.S. Food and Drug Administration (FDA) has granted clearance for its NeuroStar Advanced Therapy system as an adjunct …
FDA Clears NeuroStar’s TMS Therapy for Adolescents with Major Depressive Disorder Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM), a leading name in the field of non-invasive treatments for mental health conditions, has announced a significant expansion of its commercial partnership with …
Neuronetics and Transformations Care Network Join Forces to Expand Availability of Innovative Depression Treatment Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM), a leading-edge medtech corporation, recently showcased robust financial results for the fourth quarter and full year of 2023, hoping to continue the upward …
Neuronetics Reports Strong Fourth Quarter and 2023 Results, Launches Patient-Oriented Program Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM), a global leader in neuroscience, is set to release its financial and operating results for the fourth quarter of 2023 on March 5, …
Neuronetics Set to Announce Q4 2023 Financial Results, Highlights Advances in Mental Health Treatment Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has unveiled a series of enhancements to its proprietary TrakStar® Patient Data Management System. These updates aim to revolutionize the way healthcare providers …
Neuronetics Revamps TrakStar System, Streamlining Patient Data Management Read More